Evaluation of a Patient Education Program for Ankylosing Spondylitis - Full Text View

Sponsors and Collaborators:	Rehazentrum Bad Eilsen Hannover Medical School
Information provided by:	Rehazentrum Bad Eilsen
ClinicalTrials.gov Identifier:	NCT00722514

Purpose

Long term disease management is essential for Ankylosing Spondylitis (AS), a chronic progressive systemic inflammatory disease of the axial skeleton. Extensive information about the disease is a necessary first step. An education program for AS was implemented to improve inpatient medical rehabilitation. In a controlled quasi-experimental multicentric study the efficacy of this program was analysed.

Condition	Intervention
Ankylosing Spondylitis Spondyloarthritis	Behavioral: patient education Behavioral: Standard Care

Genetics Home Reference related topics: ankylosing spondylitis

MedlinePlus related topics: Ankylosing Spondylitis Rehabilitation

U.S. FDA Resources

Study Type:	Interventional
Official Title:	Evaluation of a Patient Education Program for Ankylosing Spondylitis

Further study details as provided by Rehazentrum Bad Eilsen:

Study Start Date:	July 1998
Estimated Study Completion Date:	July 2001
Estimated Primary Completion Date:	February 2001 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
IG: Experimental Patient education	Behavioral: patient education complex individual antiinflammatory rehabilitation program during inpatient rehabilitation (physiotherapy, physical therapy, occupational therapy, health-promoting measures and more) and additionally Patient education 6 x 90 Minutes
CG without patient education	Behavioral: Standard Care complex individual antiinflammatory rehabilitation program during inpatient complex individual medical rehabilitation (physiotherapy, physical therapy, occupational therapy, health-promoting measures and more) and additionally further 6 treatments from available disciplines(e.g. massage, electrotherapy, bath)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Ankylosing Spondylitis (AS) according to modified New York Criteria
Early diagnosis criteria for AS
ESSG Criteria for Spondyloarthritis

Exclusion Criteria:

History of malignant disease during past five years
Secondary fibromyalgia syndrome
Group integration deficiencies
Seminar repeaters

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00722514

Locations

Germany, Lower Saxony
Rehazentrum Bad Eilsen
Bad Eilsen, Lower Saxony, Germany, 31707

Sponsors and Collaborators

Rehazentrum Bad Eilsen

Hannover Medical School

Investigators

Principal Investigator:

Inge Ehlebracht-Koenig, MD

Rehazentrum Bad Eilsen

More Information

Responsible Party:	Rehazentrum Bad Eilsen ( Dr. Inge Ehlebracht-König )
Study ID Numbers:	0110599604
Study First Received:	July 23, 2008
Last Updated:	August 14, 2008
ClinicalTrials.gov Identifier:	NCT00722514
Health Authority:	Germany: Ministry of Health

Study placed in the following topic categories:

Spinal Diseases
Musculoskeletal Diseases
Spondylarthropathy
Arthritis
Joint Diseases
Spondylitis, Ankylosing

Bone Diseases
Spondylarthritis
Spondylitis
Ankylosis
Spondylarthropathies

Additional relevant MeSH terms:

Infection
Bone Diseases, Infectious

ClinicalTrials.gov processed this record on January 16, 2009